Home NDC 0024-1171 Plavix
Product NDC 0024-1171
11-digit product format 000241171
Labeler code 0024
Product ID 0024-1171_ed60a9e7-49f4-469c-bb7a-08e1bb6057e2
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name clopidogrel
Dosage form TABLET, FILM COATED
Route ORAL
Labeler Sanofi-Aventis U.S. LLC
Application NDA020839
Marketing category NDA
Marketing start 1997-11-17
Substance CLOPIDOGREL BISULFATE
Active strength 75 mg/1
Pharmacologic classes Cytochrome P450 2C8 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N020839-001 PLAVIX CLOPIDOGREL BISULFATE EQ 75MG BASE TABLET / ORAL AB RLD 1997-11-17 N020839-002 PLAVIX CLOPIDOGREL BISULFATE EQ 300MG BASE TABLET / ORAL AB RLD 2007-09-20
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 2 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 3 · 84 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 N020839-001 PLAVIX EQ 75MG BASE TABLET / ORAL AB RLD 1997-11-17 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N020839-002 PLAVIX EQ 300MG BASE TABLET / ORAL AB RLD 2007-09-20 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N020839-001 PLAVIX EQ 75MG BASE TABLET / ORAL AB RLD 1997-11-17 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N020839-002 PLAVIX EQ 300MG BASE TABLET / ORAL AB RLD 2007-09-20 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N020839-001 PLAVIX EQ 75MG BASE TABLET / ORAL AB RLD 1997-11-17 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N020839-002 PLAVIX EQ 300MG BASE TABLET / ORAL AB RLD 2007-09-20 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N020839-001 PLAVIX EQ 75MG BASE TABLET / ORAL AB RLD 1997-11-17 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N020839-002 PLAVIX EQ 300MG BASE TABLET / ORAL AB RLD 2007-09-20 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N020839-001 PLAVIX EQ 75MG BASE TABLET / ORAL AB RLD 1997-11-17 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N020839-002 PLAVIX EQ 300MG BASE TABLET / ORAL AB RLD 2007-09-20 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N020839-001 PLAVIX EQ 75MG BASE TABLET / ORAL AB RLD 1997-11-17 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N020839-002 PLAVIX EQ 300MG BASE TABLET / ORAL AB RLD 2007-09-20 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N020839-001 PLAVIX EQ 75MG BASE TABLET / ORAL AB RLD 1997-11-17 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N020839-002 PLAVIX EQ 300MG BASE TABLET / ORAL AB RLD 2007-09-20 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N020839-001 PLAVIX EQ 75MG BASE TABLET / ORAL AB RLD 1997-11-17 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N020839-002 PLAVIX EQ 300MG BASE TABLET / ORAL AB RLD 2007-09-20 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N020839-001 PLAVIX EQ 75MG BASE TABLET / ORAL AB RLD 1997-11-17 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N020839-002 PLAVIX EQ 300MG BASE TABLET / ORAL AB RLD 2007-09-20 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N020839-001 PLAVIX EQ 75MG BASE TABLET / ORAL AB RLD 1997-11-17 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N020839-002 PLAVIX EQ 300MG BASE TABLET / ORAL AB RLD 2007-09-20 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N020839-001 PLAVIX EQ 75MG BASE TABLET / ORAL AB RLD 1997-11-17 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N020839-002 PLAVIX EQ 300MG BASE TABLET / ORAL AB RLD 2007-09-20 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N020839-001 PLAVIX EQ 75MG BASE TABLET / ORAL AB RLD 1997-11-17 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N020839-002 PLAVIX EQ 300MG BASE TABLET / ORAL AB RLD 2007-09-20 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N020839-001 PLAVIX EQ 75MG BASE TABLET / ORAL AB RLD 1997-11-17 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N020839-002 PLAVIX EQ 300MG BASE TABLET / ORAL AB RLD 2007-09-20 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N020839-001 PLAVIX EQ 75MG BASE TABLET / ORAL AB RLD 1997-11-17 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N020839-002 PLAVIX EQ 300MG BASE TABLET / ORAL AB RLD 2007-09-20 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N020839-001 PLAVIX EQ 75MG BASE TABLET / ORAL AB RLD 1997-11-17 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 N020839-002 PLAVIX EQ 300MG BASE TABLET / ORAL AB RLD 2007-09-20 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N020839-001 PLAVIX EQ 75MG BASE TABLET / ORAL AB RLD 1997-11-17 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N020839-002 PLAVIX EQ 300MG BASE TABLET / ORAL AB RLD 2007-09-20 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N020839-001 PLAVIX EQ 75MG BASE TABLET / ORAL AB RLD 1997-11-17 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N020839-002 PLAVIX EQ 300MG BASE TABLET / ORAL AB RLD 2007-09-20 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N020839-001 PLAVIX EQ 75MG BASE TABLET / ORAL AB RLD 1997-11-17 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N020839-002 PLAVIX EQ 300MG BASE TABLET / ORAL AB RLD 2007-09-20 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N020839-001 PLAVIX EQ 75MG BASE TABLET / ORAL AB RLD 1997-11-17 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N020839-002 PLAVIX EQ 300MG BASE TABLET / ORAL AB RLD, RS 2007-09-20 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N020839-001 PLAVIX EQ 75MG BASE TABLET / ORAL AB RLD 1997-11-17 bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 N020839-002 PLAVIX EQ 300MG BASE TABLET / ORAL AB RLD 2007-09-20 bb7c543d1eb4…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 3 · 84 observed states.
Observed Orange Book patent history# Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2019-12-13 00:20 UTC 2019-12 N020839-001 6429210 2019-06-10 Drug substance, Drug product 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N020839-001 6504030 2019-06-10 Drug substance 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N020839-001 6429210*PED 2019-12-10 Pediatric extension 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N020839-001 6504030*PED 2019-12-10 Pediatric extension 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N020839-002 6429210 2019-06-10 Drug substance, Drug product 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N020839-002 6504030 2019-06-10 Drug substance 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N020839-002 6429210*PED 2019-12-10 Pediatric extension 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N020839-002 6504030*PED 2019-12-10 Pediatric extension 74a2ff9319b5…2019-12-14 00:12 UTC 2019-12 N020839-001 6429210 2019-06-10 Drug substance, Drug product 3f01610625f2…2019-12-14 00:12 UTC 2019-12 N020839-001 6504030 2019-06-10 Drug substance 3f01610625f2…2019-12-14 00:12 UTC 2019-12 N020839-001 6429210*PED 2019-12-10 Pediatric extension 3f01610625f2…2019-12-14 00:12 UTC 2019-12 N020839-001 6504030*PED 2019-12-10 Pediatric extension 3f01610625f2…2019-12-14 00:12 UTC 2019-12 N020839-002 6429210 2019-06-10 Drug substance, Drug product 3f01610625f2…2019-12-14 00:12 UTC 2019-12 N020839-002 6504030 2019-06-10 Drug substance 3f01610625f2…2019-12-14 00:12 UTC 2019-12 N020839-002 6429210*PED 2019-12-10 Pediatric extension 3f01610625f2…2019-12-14 00:12 UTC 2019-12 N020839-002 6504030*PED 2019-12-10 Pediatric extension 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N020839-001 6429210 2019-06-10 Drug substance, Drug product b00525d2431f…2019-09-15 20:21 UTC 2019-09 N020839-001 6504030 2019-06-10 Drug substance b00525d2431f…2019-09-15 20:21 UTC 2019-09 N020839-001 6429210*PED 2019-12-10 Pediatric extension b00525d2431f…2019-09-15 20:21 UTC 2019-09 N020839-001 6504030*PED 2019-12-10 Pediatric extension b00525d2431f…2019-09-15 20:21 UTC 2019-09 N020839-002 6429210 2019-06-10 Drug substance, Drug product b00525d2431f…2019-09-15 20:21 UTC 2019-09 N020839-002 6504030 2019-06-10 Drug substance b00525d2431f…2019-09-15 20:21 UTC 2019-09 N020839-002 6429210*PED 2019-12-10 Pediatric extension b00525d2431f…2019-09-15 20:21 UTC 2019-09 N020839-002 6504030*PED 2019-12-10 Pediatric extension b00525d2431f…2019-07-19 19:46 UTC 2019-07 N020839-001 6429210 2019-06-10 Drug substance, Drug product ea99ee380514…2019-07-19 19:46 UTC 2019-07 N020839-001 6504030 2019-06-10 Drug substance ea99ee380514…2019-07-19 19:46 UTC 2019-07 N020839-001 6429210*PED 2019-12-10 Pediatric extension ea99ee380514…2019-07-19 19:46 UTC 2019-07 N020839-001 6504030*PED 2019-12-10 Pediatric extension ea99ee380514…2019-07-19 19:46 UTC 2019-07 N020839-002 6429210 2019-06-10 Drug substance, Drug product ea99ee380514…2019-07-19 19:46 UTC 2019-07 N020839-002 6504030 2019-06-10 Drug substance ea99ee380514…2019-07-19 19:46 UTC 2019-07 N020839-002 6429210*PED 2019-12-10 Pediatric extension ea99ee380514…2019-07-19 19:46 UTC 2019-07 N020839-002 6504030*PED 2019-12-10 Pediatric extension ea99ee380514…
Additional Listing Data#
Finished product Yes
Brand name base Plavix
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength CLOPIDOGREL BISULFATE 75 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 08I79HTP27 Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 4 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 213169 Internal RxNorm lookup 309362 Internal RxNorm lookup 749196 Internal RxNorm lookup 749198 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 0024-1171-90 Plavix 90 in 1 BOTTLE TABLET, FILM COATED 90 5
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 0024-1171 PLAVIX (CLOPIDOGREL) TABLET, FILM COATED [SANOFI-AVENTIS U.S. LLC] 4 Current NDC, Legacy NDC, 1 package rows 20240822_de8b0b67-eb25-4684-83b5-7ad785314227.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Plavix CLOPIDOGREL Sanofi-Aventis U.S. LLC de8b0b67-eb25-4684-83b5-7ad785314227 2025-05-30 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (NDA): 020839 application number: NDA020839 ndc (product): 0024-1171
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 0024-1171-90 00024117190 90 TABLET, FILM COATED in 1 BOTTLE (0024-1171-90) 2020-07-13 0000-00-00 No No Current